NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NutriBand's total debt was $25.10K at Jul 31, 2026. For fiscal 2026 it was $35.86K, down 38.4% from the year before. The highest annual figure on record is $2.08M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $35.86K | -38.4% |
| FY2025 | Jan 31, 2025 | $58.21K | -97.2% |
| FY2024 | Jan 31, 2024 | $2.08M | +1969.5% |
| FY2023 | Jan 31, 2023 | $100.50K | -0.6% |
| FY2022 | Jan 31, 2022 | $101.12K | -32.6% |
| FY2021 | Jan 31, 2021 | $150.06K | – |
| FY2019 | Jan 31, 2019 | $0 | -100.0% |
| FY2018 | Jan 31, 2018 | $16.05K | +49.9% |
| FY2017 | Jan 31, 2017 | $10.71K | +1.0% |
| FY2016 | Jan 31, 2016 | $10.60K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $25.10K | -46.9% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $29.83K | -43.3% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $35.86K | -38.4% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $41.60K | -34.7% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $47.29K | -31.6% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $52.63K | -29.4% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $58.21K | -97.2% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $63.72K | -25.1% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $69.13K | -23.4% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $74.51K | -21.9% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $2.08M | +1969.5% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $85.10K | -19.3% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $90.26K | -22.0% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $95.43K | -17.6% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $100.50K | -0.6% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $105.51K | +0.9% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $115.75K | +3.7% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $115.75K | -22.9% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $101.12K | -40.0% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $104.60K | +200.0% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $111.61K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $150.06K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $168.42K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $34.87K | -14.8% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $0 | -100.0% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $0 | -100.0% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $0 | -100.0% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $40.91K | +237.7% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $16.05K | +49.9% |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $16.70K | -39.9% |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $11.45K | -35.8% |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $12.11K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | $10.71K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | $27.77K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | $17.83K | – |
See a number that looks wrong?